McBride (LON:MCB) Shares Cross Above Two Hundred Day Moving Average – Here’s What Happened

McBride plc (LON:MCB)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 127.50 and traded as high as GBX 154.80. McBride shares last traded at GBX 154, with a volume of 1,967,501 shares changing hands.

More McBride News

Here are the key news stories impacting McBride this week:

• Positive Sentiment: McBride announced it will host an investor webinar on 26 February 2026 to discuss interim results — this typically supports short-term investor interest and can drive buying ahead of management commentary. McBride to Host Investor Webinar Following Interim Results
• Neutral Sentiment: Multiple sports articles about New York Knicks players (Miles/“Deuce” McBride) reporting core muscle/sports hernia injuries — these are sports headlines and have no material bearing on McBride plc’s business or stock fundamentals. Links to the articles provided: Report: Knicks’ Deuce McBride to miss considerable time with sports hernia McBride had additional evaluations to some other The ‘give-and-go’ injury recovery that will determine if Knicks’ Miles McBride can return for playoffs
• Neutral Sentiment: Additional coverage detailing Miles McBride’s likely surgery and absence (various outlets) — again, sports-focused and not relevant to McBride plc investor decisions. Knicks guard Miles McBride reportedly set for core muscle surgery, likely out until playoffs Miles McBride needs surgery in major Knicks injury blow
• Neutral Sentiment: Knicks injury-tracker and local reporting on McBride’s status — informational for sports readers but not applicable to McBride plc’s corporate outlook. Knicks Injury Tracker: Josh Hart, Miles McBride ruled out for Wednesday vs. Nuggets Knicks’ Miles McBride needs core surgery and could be out for the season Key Knicks Reserve Deuce McBride Out Indefinitely With Core Muscle Surgery

Analyst Upgrades and Downgrades

Separately, Peel Hunt restated a “buy” rating and issued a GBX 190 target price on shares of McBride in a research report on Thursday, November 20th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of GBX 190.

McBride Stock Up 1.0%

The company has a market capitalization of £274.09 million, a price-to-earnings ratio of 8.51, a PEG ratio of -0.36 and a beta of 1.17. The firm’s 50 day simple moving average is GBX 141.83 and its 200-day simple moving average is GBX 127.65. The company has a current ratio of 0.92, a quick ratio of 0.54 and a debt-to-equity ratio of 222.08.

McBride announced that its board has authorized a stock buyback plan on Monday, December 1st that permits the company to repurchase 0 outstanding shares. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are typically a sign that the company’s board believes its shares are undervalued.

McBride Company Profile

With trading roots dating back to 1927, McBride boasts a strong heritage. As the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning and hygiene markets, McBride offers end‑to‑end development and manufacturing capabilities to a wide range of customers in Europe and Asia Pacific.